Detection and Quantification of Myocardial Scars by Contrast-Enhanced 3D Echocardiography

Background—Myocardial infarct scars are usually imaged by delayed-enhanced cardiac magnetic resonance (DE-cMR). In this study, we tested the hypothesis that the detection and quantification of myocardial scars can be evaluated by 3D echocardiography (3D-echo). Methods and Results—Fifty patients with a healed myocardial infarction (>3 months) and 10 controls underwent 3D echo and DE-cMR within 2 weeks. 3D-echo images were acquired with different settings, with or without contrast. The highest contrast-to-noise ratio was obtained with second-harmonic imaging (1.6/3.2 MHz), at a mechanical index of 0.5, in the presence of contrast. Using this modality, we calculated the sensitivity and specificity of the 3D-echo detection of cMR scars on a segmental basis to be 78% and 99%, respectively. On a per-patient basis, they were 96% and 90%, respectively. Good correlation and limits of agreement were found between the assessment of scar mass by 3D echo and DE-cMR (r=0.93, P<0.001; bias, 1.4±3.6 g), and the concordance between both techniques for the assessment of scar transmurality was good. Intraobserver, interobserver, and day-to-day reproducibility was comparable between 3D echo and DE-cMR for both the detection and quantification of scars. Conclusions—Contrast-enhanced 3D echo is a promising new tool for the detection and quantification of myocardial infarct scars.

[1]  Jonathan Chan,et al.  Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging. , 2008, European heart journal.

[2]  B. Gerber,et al.  Is postsystolic shortening a marker of viability in chronic left ventricular ischemic dysfunction? Comparison with late enhancement contrast magnetic resonance imaging. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[3]  R. Senior,et al.  Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time? , 2008, European heart journal.

[4]  Victor Mor-Avi,et al.  Three-dimensional echocardiography: the benefits of the additional dimension. , 2006, Journal of the American College of Cardiology.

[5]  Peter Whittaker,et al.  Collagen Fiber Morphology Determines Echogenicity of Myocardial Scar: Implications for Image Interpretation , 2006, Echocardiography.

[6]  J J Bax,et al.  Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction , 2005, Heart.

[7]  R. Kim,et al.  Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. , 2005, European heart journal.

[8]  U. Haberkorn,et al.  Comparison of real-time myocardial contrast echocardiography for the assessment of myocardial viability with fluorodeoxyglucose-18 positron emission tomography and dobutamine stress echocardiography. , 2004, The American journal of cardiology.

[9]  Marcus Schreckenberg,et al.  High-resolution transthoracic real-time three-dimensional echocardiography: quantitation of cardiac volumes and function using semi-automatic border detection and comparison with cardiac magnetic resonance imaging. , 2004, Journal of the American College of Cardiology.

[10]  Jeroen J. Bax,et al.  Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. , 2004, European heart journal.

[11]  M. Verani,et al.  Identification of Hibernating Myocardium With Quantitative Intravenous Myocardial Contrast Echocardiography: Comparison With Dobutamine Echocardiography and Thallium-201 Scintigraphy , 2003, Circulation.

[12]  L. Shaw,et al.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. , 2002, Journal of the American College of Cardiology.

[13]  R. Kim,et al.  Transmural Extent of Acute Myocardial Infarction Predicts Long-Term Improvement in Contractile Function , 2001, Circulation.

[14]  D A Bluemke,et al.  Relation Between Gd-DTPA Contrast Enhancement and Regional Inotropic Response in the Periphery and Center of Myocardial Infarction , 2001, Circulation.

[15]  T. Marwick,et al.  Effect of power Doppler and digital subtraction techniques on the comparison of myocardial contrast echocardiography with SPECT , 2001, Heart.

[16]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[17]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[18]  A. Pasquet,et al.  Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. , 1999, Circulation.

[19]  B. Gerber,et al.  Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. , 1996, Journal of the American College of Cardiology.

[20]  S. M. Collins,et al.  Assessment of fibrosis in infarcted human hearts by analysis of ultrasonic backscatter. , 1985, Circulation.

[21]  F J Schoen,et al.  Enhanced Detection of the Evolution of Tissue Changes After Acute Myocardial Infarction Using Color‐encoded Two‐dimensional Echocardiography , 1982, Circulation.

[22]  S B Knoebel,et al.  Detection of Myocardial Scar Tissue by M‐Mode Echocardiography , 1978, Circulation.

[23]  O. Rimoldi,et al.  Stunning, Hibernation, and Assessment of Myocardial Viability , 2008, Circulation.